Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic

Francesco Motolese, Francesca Ursini, Davide Norata, Fioravante Capone, Elisabetta Sapio, Maria Luisa Di Giesi, Silvia Antonella Selvaggi, Gabriele Annesi, Mariagrazia Rossi, Rosalinda Calandrelli, Carlo Augusto Mallio, Caterina Bernetti, Michele Tondo, Bruno Beomonte Zobel, Eliodoro Faiella, Fabio Pilato, Vincenzo Di Lazzaro

Open source

DOI: 10.1177/13872877261488813
Published: 2026-09-28
Container: Journal of Alzheimer’s Disease
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/13872877261488813,
  title = {Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic},
  author = {Francesco Motolese and Francesca Ursini and Davide Norata and Fioravante Capone and Elisabetta Sapio and Maria Luisa Di Giesi and Silvia Antonella Selvaggi and Gabriele Annesi and Mariagrazia Rossi and Rosalinda Calandrelli and Carlo Augusto Mallio and Caterina Bernetti and Michele Tondo and Bruno Beomonte Zobel and Eliodoro Faiella and Fabio Pilato and Vincenzo Di Lazzaro},
  year = {2026},
  journal = {Journal of Alzheimer’s Disease},
  doi = {10.1177/13872877261488813},
  url = {https://doi.org/10.1177/13872877261488813}
}

RIS

TY  - JOUR
TI  - Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic
AU  - Francesco Motolese
AU  - Francesca Ursini
AU  - Davide Norata
AU  - Fioravante Capone
AU  - Elisabetta Sapio
AU  - Maria Luisa Di Giesi
AU  - Silvia Antonella Selvaggi
AU  - Gabriele Annesi
AU  - Mariagrazia Rossi
AU  - Rosalinda Calandrelli
AU  - Carlo Augusto Mallio
AU  - Caterina Bernetti
AU  - Michele Tondo
AU  - Bruno Beomonte Zobel
AU  - Eliodoro Faiella
AU  - Fabio Pilato
AU  - Vincenzo Di Lazzaro
PY  - 2026
JO  - Journal of Alzheimer’s Disease
DO  - 10.1177/13872877261488813
UR  - https://doi.org/10.1177/13872877261488813
ER  -

APA

Motolese, F., Ursini, F., Norata, D., Capone, F., Sapio, E., Giesi, M. L. D., Selvaggi, S. A., Annesi, G., Rossi, M., Calandrelli, R., Mallio, C. A., Bernetti, C., Tondo, M., Zobel, B. B., Faiella, E., Pilato, F., & Lazzaro, V. D. (2026). Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261488813

Source records

crossref · retrieved 2026-11-10T18:05:07.858Z